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rare. As of 2014, only 29 cases of IgG4-related hypophysitis
have been reported.1 In this study, we present two cases of
LH and one of IgG4-related disease, manifested with IgG4-
related hypophysitis, pancreatitis, and tubulointerstitial
nephritis.
The first LH case is a 47-year-old male marked with pan-
hypopituitarism (endocrine assessment results in Table 1).
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magnetic resonance imaging (MRI) results in both cases
mimicked pituitary adenoma (Figures 1A and 1F), while
serum IgG4 level was normal. A diagnosis of LH was
confirmed by endoscopic transphenoidal surgery (Figures
1CeE, 1HeJ, and 1O). Regression of pituitary lesion after
hormone replacement was observed on follow-up MRI scans
(Figures 1B and 1G). The third patient is a 56-year-old male
with central diabetes insipidus confirmed by a water depri-
vation plus desmopressin test, in which urine osmolarity
reached a plateau at 150 mOsm/kg 3e4 hours after water
deprivation and then increased to 283 mOsm/kg 1 hour after
desmopressin administration. Desmopressin therapy was
instituted. Compatible findings of pituitary stalk thickening
and a loss of the posterior pituitary bright spot were
observed on MRI (Figure 1K). Both a high level of serum IgG4
(570.7 mg/dL) and computed tomography (CT) image find-
ings suggestive of autoimmune pancreatitis and autoimmune
tubulointerstitial nephritis indicated IgG4-related diseasehypophysitis, i.e., two cases of lymphocytic hypophysitis and one
o allow early diagnosis and prompt treatment for the IgG4-related
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Table 1 Results of endocrine assessment.
Hormone Case 1 Case 2 Case 3 Reference
8 AM cortisol (mg/dL) 0.1 11.6 3.5a 5e25
8 AM ACTH (pg/mL) 8.7 23.01 20.2 <46
10 PM cortisol (mg/dL) d 2.94 d <5
10 PM ACTH (pg/mL) d <5 d <46
Free T4 (ng/dL) 0.41 2.31 0.96 0.8e1.9
T3 (ng/dL) d 318 d 82e179
TSH (mIU/mL) 0.09 <0.004 2.08 0.4e4.0
TSH receptor antibody (%) d 50 d 10
Testosterone (ng/mL) <0.08 d 4.19 1.7e8.4
Estrogen (pg/mL) d 37.38 d 27e125
FSH (mIU/mL) 0.9 7.19 5.2 M: 3e19; F: 3e8.7
LH (mIU/mL) 0.05 2.71 4.05 M: 1.2e10: F: 2e11
Prolactin (ng/mL) 21.6 0.86 20.8 2.5e18.1
IGF-1 (ng/mL) d 117.0 115.0 81e225 (56e60-y-old male)
GH (ng/mL) 0.1 0.3 <0.1 <5 ng/mL
AFP (ng/mL) 3.19 d 3.45 0e20
b-hCG (mIU/mL) <1.2 d <1.2 <10
IgG4 (mg/dL) 15.2 103.5 570.7 3.9e86.4
ACTH Z adrenocorticotrophic hormone; AFP Z alpha fetoprotein; b-hCG Z beta human chorionic gonadotropin; FSH Z follicle-
stimulating hormone; GH Z growth hormone; IGF-1 Z insulin-like growth factor 1; IgG4 Z immunoglobulin G4; LH Z luteinizing
hormone; T3 Z triiodothyronine; T4 Z thyroxine; TSH Z thyroid stimulating hormone.
a Increased to 19 mg/dL 1 hour after 5 mg cosyntropin (ACTH1e24).
Figure 1 Case 1: (A) A 1.5-cm homogeneously enhanced tumor occupying the entire pituitary gland with pituitary stalk exten-
sion. (B) A 0.9-cm regressive pituitary lesion on follow-up MRI 4 months after operation. (C) Diffuse lymphocyte and plasma cell
infiltration in the adenohypophyseal tissue. The lymphoid cells were positive for (D) B-cell marker CD20 and (E) T-cell marker CD3
by immunostaining. Case 2: (F) A 2.3-cm heterogeneously enhanced tumor in the pituitary fossa with left-side predominance. (G) A
regressive change in the pituitary lesion from 2.3 cm to 0.7 cm on follow-up MRI. (H) Marked interstitial fibrosis and (I) abundant
chronic inflammatory cells, including lymphocytes, histiocytes, and plasma cells, occupied the adenohypophyseal tissue. The cell
aggregates were positive for (J) B-cell marker CD20 and (O) T-cell marker CD3 by immunostaining. Case 3: (K) A 1.5-cm pituitary
lesion with pituitary stalk thickening and loss of the physiologic bright spot over the posterior lobe. (L) A marginal regressive change
in the pituitary lesion from 1.5 cm to 1.2 cm on follow-up MRI. (M) Autoimmune type 1 (IgG4-related) pancreatitis is suggested by
diffusely enlarged pancreas with poor arterial enhancement, peripancreatic low attenuation capsule-like rim, and mild peri-
pancreatic fat stranding on CT scan of the abdomen. (N) Multiple areas of poor contrast enhancement at peripheral cortical
nodules, causing well-defined, wedge-shaped lesions that may be compatible with IgG4-related tubulointerstitial nephritis.
CT Z computed tomography; IgG4 Z immunoglobulin G4; MRI Z magnetic resonance imaging.
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+ MODEL(Figures 1M and 1N). After prednisolone therapy (40mg daily,
tapering to 10 mg daily), resolution of pancreatitis and
nephritis on follow-up CT scan and a decrease in serum IgG4
and in the size of the lesion on pituitary MRI were noted
(Figure 1L).
In the absence of typical MRI features of hypophysitis
such as symmetrically enlarged pituitary gland,2 our LH
cases were confirmed by pathology, as it would otherwise
be somewhat difficult to differentiate it from pituitary
adenomas. The case of IgG4-related hypophysitis was
diagnosed based on the criteria defined by Leporati et al,3
namely, criterion 2 (a thickened pituitary stalk on pitui-
tary MRI), criterion 4 (serum IgG4 levels >140 mg/dL), and
criterion 5 (shrinkage of the pituitary lesion after gluco-
corticoid therapy). Most patients with IgG4-related hypo-
physitis had other IgG4-related symptoms, with
retroperitoneal fibrosis being the most common (38%),
followed by autoimmune pancreatitis (24%), while IgG4-
related tubulointerstitial nephritis appeared to be less
common.4
Hormone replacement therapy together with observa-
tion is the preferred treatment for LH. Using observation
alone, spontaneous regression in the size of the pituitary
lesion was found in 46% of patients, while it remained un-
changed in 27% and showed progress in another 27%. Pitu-
itary function improved in 27% of patients.5 Consistent with
the literature, favorable outcomes were observed in the
third patient under glucocorticoid therapy and in the twoPlease cite this article in press as: Huang C-J, et al., A study of primary
IgG4-related variant: The importance of measuring serum IgG4 levels t
variant, Journal of the Formosan Medical Association (2016), http://dLH cases using observation and hormone replacement
therapy.
We concluded that, although rare, primary hypophysitis
should be considered in the differential diagnosis of sellar
mass. Furthermore, the presence of the IgG4-related
variant should be investigated by obtaining a serum IgG4
level leading to discover a novel endocrinopathy in its very
early stage to avoid a lifelong hormone replacement
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